The SENTRY Antimicrobial Surveillance Program is Element's flagship surveillance study that has been ongoing since its establishment in 1997. It is one of the longest running antimicrobial surveillance programs that monitors worldwide pathogens and the changes in resistance patterns over time through centralized testing and utilizing reference susceptibility methods.
The SENTRY Microbiology Visualization Platform (MVP) provides best in class mechanisms to analyze isolates collected as part of the SENTRY program. Reports are generated using the latest CLSI, EUCAST, and US FDA criteria where available.